VEGF-D (human, recombinant)
Active • Host: HEK293 cells • AA: 93-201 • Tag: C-terminal His • MW: 13.6 kDa
Item No. 32055
Formulation: Lyophilized from sterile PBS, pH 7.4, 5% trehalose, 5% mannitol, and 0.01% Tween-80
Purity: ≥95% as determined by SDS-PAGE.
- c-Fos-induced Growth Factor
- FIGF
- Vascular Endothelial Growth Factor D
VEGF-C (human, recombinant)
Active • Host: HEK293 cells • AA: 103-227 • Tag: C-terminal His • MW: 15.5 kDa
Item No. 32054
Formulation: Lyophilized from sterile PBS, pH 7.4, with 5% trehalose, 5% mannitol, and 0.01% Tween 80
Purity: ≥95% estimated by SDS-PAGE
- FLT4-L
- FLT4 Ligand
- Vascular Endothelial Growth Factor C
Formulation: Lyophilized from sterile 20 mM tris, pH 8.0, and 150 mM sodium chloride
Purity: ≥95% as estimated by SDS-PAGE
- Vascular Endothelial Growth Factor A 165 variant
VEGF-A 164 variant (mouse, recombinant)
Active • Host: Insect cells (baculovirus) • AA: 27-190 • MW: 19.4 kDa
Item No. 32068
Formulation: Lyophilized from sterile 100 mM glycine, 20 mM sodium chloride, pH 7, and 22.5% trehalose
Purity: ≥90% estimated by SDS-PAGE
- Vascular Endothelial Growth Factor A 164 variant
VEGFR2 Kinase Inhibitor I
A potent, cell-permeable inhibitor of VEGFR2
CAS No. 15966-93-5
Item No. 13578
Formulation: A crystalline solid
Purity: ≥95%
- SU 5408
VEGFR2 Kinase Inhibitor II
A potent, cell-permeable inhibitor of VEGFR2
CAS No. 288144-20-7
Item No. 17544
Formulation: A crystalline solid
Purity: ≥95%
Formulation: A solid
Purity: ≥98%
- Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor IV
Formulation: A solid
Purity: ≥98%
- Tie2/VEGFR2 Kinase Inhibitor 2
- Tie2/Vascular Endothelial Growth Factor Receptor 2 Kinase-IN-2
- Tie2/Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor 2
- Tunica Interna Endothelial Cell Kinase 2/Vascular Endothelial Growth Factor Receptor 2 Kinase-IN-2
- Tunica Interna Endothelial Cell Kinase 2/Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor 2
- Tunica Interna Endothelial Cell Kinase 2/VEGFR2-IN-2
- Tunica Interna Endothelial Cell Kinase 2/VEGFR2 Inhibitor 2
VEGFR3 Extracellular Domain (human, recombinant)
Active • Host: HEK293 cells • AA: 25-776 • Tag: C-terminal His • MW: 86 kDa
Item No. 33746
Formulation: Lyophilized from sterile PBS, pH 7.4
Purity: ≥97% estimated by SDS-PAGE
- FLT4
- Fms-like Tyrosine Kinase 4
- Tyrosine-protein Kinase Receptor FLT4
- Vascular Endothelial Growth Factor Receptor 3
Immunogen: A peptide corresponding to residues near the C-terminus of human VEGFR2
Host: Rabbit
Isotype: IgG
Applications: IHC, WB
VEGFR2 Extracellular Domain (human, recombinant; aa 20-327)
Active • Host: HEK293 cells • AA: 20-327 • Tag: C-terminal human IgG1 Fc • MW: 61.5 kDa
Item No. 31845
Formulation: Lyophilized from sterile PBS, pH 7.4
Purity: ≥95% estimated by SDS-PAGE
- CD309
- Fetal Liver Kinase 1
- FLK1
- FLK-1
- KDR
- Kinase Insert Domain Receptor
- Vascular Endothelial Growth Factor Receptor 2
VEGFR Tyrosine Kinase Inhibitor II
An inhibitor of KDR, FLT1, and c-Kit
CAS No. 269390-69-4
Item No. 17654
Formulation: A crystalline solid
Purity: ≥98%
- Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor II
VEGF-A (C-Term) Rabbit Monoclonal Antibody (RM391)
For immunochemical detection of VEGF-A
Item No. 32323
Formulation: 100 µl of protein A-affinity purified monoclonal antibody
- Vascular Endothelial Growth Factor A
- Vascular Permeability Factor
- VEGF
Formulation: A solid
Purity: ≥98%
- Human Vascular Endothelial Growth Factor Inhibitor 1
Formulation: A crystalline solid
Purity: ≥98%
- CB-676475
Formulation: A crystalline solid
Purity: ≥95%
Formulation: A crystalline solid
Purity: ≥98%
- AZD 2171
- ZD 2171
Vatalanib (hydro
A potent and selective VEGF receptor inhibitor
CAS No. 212141-51-0
Item No. 14868
Formulation: A crystalline solid
Purity: ≥98%
- CGP 79787
- PTK787
- PTK/ZK
Formulation: A solid
Purity: ≥90%
Formulation: A solid
Purity: ≥98%
- HMPL-013
Neuropilin-2a Extracellular Domain (human, recombinant)
Active • Host: HEK293 cells • AA: 23-855 • Tag: C-terminal His • MW: 95 kDa
Item No. 38068
Formulation: Lyophilized from sterile PBS, pH 7.4
Purity: ≥95% estimated by SDS-PAGE
- NRP2a
- Vascular Endothelial Cell Growth Factor165 Receptor 2a
- VEGF165 Receptor 2a
Formulation: A 500 µg/ml solution in ethanol
Purity: ≥98%
Formulation: A crystalline solid
Purity: ≥95%
Formulation: A solid
Purity: ≥95%
- Nicotinic Acid adenine dinucleotide phosphate
Formulation: A solid
Purity: ≥98%
- NSC 247030
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
